年季 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 |
---|---|---|---|---|---|---|---|---|---|---|
營業收入淨額 | 5,492,000 | 5,672,000 | 5,617,000 | 5,454,000 | 5,311,000 | 4,958,000 | 4,395,000 | 4,651,000 | 4,362,000 | 4,126,000 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 5,492,000 | 5,672,000 | - | - | 5,311,000 | - | 4,395,000 | 4,651,000 | 4,362,000 | 4,126,000 |
營業費用 | 2,462,000 | 2,452,000 | - | - | 2,540,000 | - | 2,180,000 | 2,194,000 | 2,413,000 | 2,266,000 |
研發費用 | - | - | - | - | - | - | - | - | - | - |
推銷及管理費用 | 2,396,000 | 2,386,000 | 2,252,000 | 2,209,000 | 2,453,000 | 2,778,000 | 2,120,000 | 2,152,000 | 2,309,000 | 2,166,000 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | 31,000 |
其他營業費用 | 66,000 | 66,000 | 82,000 | 70,000 | 87,000 | 79,000 | 60,000 | 42,000 | 104,000 | 69,000 |
營業利益 | 3,030,000 | 3,220,000 | - | - | 2,771,000 | - | 2,215,000 | 2,457,000 | 1,949,000 | 1,860,000 |
其他收入及費用 | - | - | - | - | - | - | - | - | - | - |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | 822,000 | 960,000 | 925,000 | 912,000 | 598,000 | 201,000 | 511,000 | 916,000 | 688,000 | 889,000 |
所得稅 | 178,000 | 177,000 | 195,000 | 201,000 | 135,000 | -9,000 | 89,000 | 153,000 | 139,000 | 156,000 |
稅後純益 | 644,000 | 783,000 | 730,000 | 711,000 | 463,000 | 210,000 | 422,000 | 763,000 | 549,000 | 733,000 |
基本每股稅後盈餘(元) | 2.07 | 2.50 | 2.29 | 2.18 | 1.38 | 0.56 | 1.27 | 2.20 | 1.54 | 1.94 |
稀釋每股稅後盈餘(元) | 2.04 | 2.44 | 2.25 | 2.15 | 1.37 | 0.61 | 1.29 | 2.16 | 1.52 | 1.91 |
基本平均股數(千股) | 288562.00 | 291686.00 | 297365.00 | 300564.00 | 301991.00 | 306198.00 | 313147.00 | 329383.00 | 341106.00 | 359200.00 |
稀釋平均股數(千股) | 292716.00 | 296420.00 | 301847.00 | 304765.00 | 305943.00 | 310419.00 | 317329.00 | 333540.00 | 345472.00 | 363923.00 |
還原基本每股稅後盈餘(元) | 2.07 | 2.50 | 2.29 | 2.18 | 1.38 | 0.56 | 1.27 | 2.20 | 1.54 | 1.94 |
還原稀釋每股稅後盈餘(元) | 2.04 | 2.44 | 2.25 | 2.15 | 1.37 | 0.61 | 1.29 | 2.16 | 1.52 | 1.91 |
還原基本平均股數(千股) | 288,562 | 291,686 | 297,365 | 300,564 | 301,991 | 306,198 | 313,147 | 329,383 | 341,106 | 359,200 |
還原稀釋平均股數(千股) | 292,716 | 296,420 | 301,847 | 304,765 | 305,943 | 310,419 | 317,329 | 333,540 | 345,472 | 363,923 |
EBITDA(千元) | 910,000 | 1,079,000 | 1,069,000 | 1,073,000 | 779,000 | 392,000 | 734,000 | 1,153,000 | 919,000 | 1,308,000 |
您已登出
若要繼續使用請重新登入
錯誤
發生錯誤,請再試一次。
您尚未登入
此功能需要登入才能使用。